Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Neurodegenerative disorders including Alzheimer's, Parkinson's, and dementia are chronic and advanced diseases that are associated with loss of neurons and other related pathologies. Furthermore, these disorders involve structural and functional defections of the blood-brain barrier (BBB)....
Saved in:
Main Authors: | Bwalya Angel Witika (Author), Madan Sai Poka (Author), Patrick Hulisani Demana (Author), Scott Kaba Matafwali (Author), Siyabonga Melamane (Author), Sandile Maswazi Malungelo Khamanga (Author), Pedzisai Anotida Makoni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of quantitative analysis and Hansen solubility parameter predictions for the selection of excipients for lipid nanocarriers to be loaded with water soluble and insoluble compounds
by: Pedzisai A. Makoni, et al.
Published: (2020) -
Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review
by: Aristote B. Buya, et al.
Published: (2021) -
Nanotechnological innovations in paediatric tuberculosis management: current trends and future prospects
by: Taiwo Oreoluwa Ajayi, et al.
Published: (2024) -
Challenges faced by blind patients using chronic medication at a tertiary hospital in South Africa
by: Madan S. Poka, et al.
Published: (2022) -
Chitosan-Coated SLN: A Potential System for Ocular Delivery of Metronidazole
by: Simise S. Sikhondze, et al.
Published: (2023)